NFO Alert: Baroda BNP Paribas Mutual Fund Launches Health and Wellness Fund

Baroda BNP Paribas Mutual Fund has announced the launch of its new fund offer (NFO) for the Baroda BNP Paribas Health and Wellness Fund, an open-ended equity scheme. The subscription window will remain open from June 9 to June 23, 2025.

Objective and Structure

The fund aims to achieve long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies operating in the pharma and healthcare sectors. There is no assurance or guarantee of returns under the scheme.

This is a sectoral fund, categorised under Equity: Sectoral – Pharma, and follows a very high-risk investment approach. It will track the BSE Healthcare TRI as its benchmark.

Key Details

• Type: Open-ended
• Minimum Investment: ₹1,000
• Plans Available: Growth and IDCW
• Lock-in Period: Not applicable
• Exit Load: 1% for redemption of units exceeding 10% of the investment within one year
• Fund House: Baroda BNP Paribas Mutual Fund
• Fund Manager: Sanjay Chawla
• Registrar: KFin Technologies Ltd.

Risk and Redemption

The fund carries a very high-risk rating as per the Riskometer. While there is no lock-in period, an exit load of 1%applies if more than 10% of the units are redeemed within 12 months from the date of allotment.

Read more: Best Mutual Funds for Lumpsum Investment for June 2025!

Target Sector

The investment universe is limited to the healthcare and pharmaceutical segments, including but not limited to companies involved in manufacturing, services, and distribution within these sectors. The scheme’s performance will be closely tied to trends in these specific industries.

Conclusion

The Baroda BNP Paribas Health and Wellness Fund offers a thematic investment option in the healthcare and pharma sectors. The NFO will close on June 23, 2025, and the minimum application amount is ₹1,000.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.